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Abstract
Background: For clinical applications of mesenchymal stem cells (MSCs), labeling and tracking is crucial to evaluate 
cell distribution and homing. Magnetic resonance imaging (MRI) has been successfully established detecting MSCs 
labeled with superparamagnetic particles of iron oxide (SPIO). Despite initial reports that labeling of MSCs with SPIO is 
safe without affecting the MSC's biology, recent studies report on influences of SPIO-labeling on metabolism and 
function of MSCs. Exposition of cells and tissues to high magnetic fields is the functional principle of MRI. In this study 
we established innovative labeling protocols for human MSCs using clinically established SPIO in combination with 
magnetic fields and investigated on functional effects (migration assays, quantification of colony forming units, 
analyses of gene and protein expression and analyses on the proliferation capacity, the viability and the differentiation 
potential) of magnetic fields on unlabeled and labeled human MSCs. To evaluate the imaging properties, 
quantification of the total iron load per cell (TIL), electron microscopy, and MRI at 3.0 T were performed.
Results: Human MSCs labeled with SPIO permanently exposed to magnetic fields arranged and grew according to the 
magnetic flux lines. Exposure of MSCs to magnetic fields after labeling with SPIO significantly enhanced the TIL 
compared to SPIO labeled MSCs without exposure to magnetic fields resulting in optimized imaging properties 
(detection limit: 1,000 MSCs). Concerning the TIL and the imaging properties, immediate exposition to magnetic fields 
after labeling was superior to exposition after 24 h. On functional level, exposition to magnetic fields inhibited the 
ability of colony formation of labeled MSCs and led to an enhanced expression of lipoprotein lipase and peroxisome 
proliferator-activated receptor-γ in labeled MSCs under adipogenic differentiation, and to a reduced expression of 
alkaline phosphatase in unlabeled MSCs under osteogenic differentiation as detected by qRT-PCR. Moreover, 
microarray analyses revealed that exposition of labeled MSCs to magnetic fields led to an up regulation of CD93 mRNA 
and cadherin 7 mRNA and to a down regulation of Zinc finger FYVE domain mRNA. Exposition of unlabeled MSCs to 
magnetic fields led to an up regulation of CD93 mRNA, lipocalin 6 mRNA, sialic acid acetylesterase mRNA, and olfactory 
receptor mRNA and to a down regulation of ubiquilin 1 mRNA. No influence of the exposition to magnetic fields could 
be observed on the migration capacity, the viability, the proliferation rate and the chondrogenic differentiation 
capacity of labeled or unlabeled MSCs.
Conclusions: In our study an innovative labeling protocol for tracking MSCs by MRI using SPIO in combination with 
magnetic fields was established. Both, SPIO and the static magnetic field were identified as independent factors which 
affect the functional biology of human MSCs. Further in vivo investigations are needed to elucidate the molecular 
mechanisms of the interaction of magnetic fields with stem cell biology.Schäfer et al. BMC Cell Biology 2010, 11:22
http://www.biomedcentral.com/1471-2121/11/22
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Background
Due to their regenerative and immunomodulatory poten-
tial mesenchymal stem cells (MSCs) provide promising
opportunities for the therapy of various diseases. For clin-
ical applications of MSCs, labeling and tracking is crucial
to evaluate cell distribution and homing. For this purpose
positron emission tomography (PET), optical imaging
(OI), and magnetic resonance imaging (MRI) were evalu-
ated in various studies [1-5]. Limitations of PET include
the poor spatial resolution [6], the radiation of the tracers
that results in cell damage, and the short half life time of
the tracers used (e.g. F-18, t1/2 110 min). OI also is a very
sensitive method widely accepted in small-animal studies
[7]. However, due to the limited tissue penetration of the
light emitted from the fluorochromes the use of OI is lim-
ited to superficial processes. Another problem is the
quantification of the signal. High-field MRI (= 1.5 T) in
combination with special high-resolution receiver coils
and innovative signal strategies might be a compromise
for clinical purposes. Advantages of MRI are the lack of
radiation exposure, the excellent spatial resolution down
to 300 μm and the fact that patient size does not limit the
examination. Furthermore, long-term studies over six
weeks already have been performed successfully [8]. To
label cells for MRI, paramagnetic substances like gadolin-
ium (Gd) DTPA [9-11] or superparamagnetic substances
(small/ultrasmall particles of iron oxide, SPIO/USPIO)
[12-16] have been used. The latter seem to be more suit-
able as iron labeling results in larger susceptibility arti-
facts and iron is less toxic than Gd. Iron-based contrast
agents are already FDA and CE approved (Endorem®
Guerbet, Paris, France; Resovist® Bayer Schering AG, Ber-
lin, Germany) and under consideration for approval
(Sinerem® Guerbet). The major differences of those parti-
cles are size (20-120 nm) and coating. SPIO-labeling of
MSCs does not affect the viability or differentiation
potential of the cells [5,17] but SPIO-labeling can have an
impact on the iron metabolism, the migration capacity
and the ability of colony formation of MSCs [17-19].
Exposition of cells and tissues to magnetic fields is not
only the functional principle of MRI, the magnetic force
c a n  a l s o  b e  u s e d  f o r  t h e  g u i d e d  l o c a l i z a t i o n  o f  i r o n -
labeled stem cells to desired regions [20,21] or for the
seeding of scaffolds with stem cells [22] or for the engi-
neering of 3D tissues by stem cells [23]. Human endothe-
lial progenitor cells and murine macrophages labeled by
iron nanoparticles were previously exposed to external
magnetic field gradients with different experimental con-
ditions and the formation of the three-dimensional multi-
cellular assemblies have been described [24]. Moreover,
magnetic-fluid-loaded liposomes were guided to the near
vicinity of human adenocarcinoma prostatic cells by
means of a 0.29-T external magnet [25]. Except for spo-
radic reports on the influence of magnetic fields on
hematopoietic progenitor cells [26], neural progenitor
cells [27] and myoblasts [28] to date no report exists
investigating on possible effects of magnetic fields on
iron-labeled and unlabeled human stem cells. In this
study an innovative labeling protocol for tracking MSCs
by MRI using SPIO in combination with magnetic fields
was established. Both, SPIO and the static magnetic field
were identified as independent factors which affect the
functional biology of human MSCs. Further in vivo inves-
tigations are needed to elucidate the molecular mecha-
nisms of the interaction of magnetic fields with stem cell
biology.
Results
Characteriztion of human MSCs
After  in vitro differentiation and specific staining, the
human MSCs showed adipogenic, osteogenic and chon-
drogenic differentiation indicating their plasticity (Figure
1A). Moreover, the human MSCs showed the typical sur-
face epitope pattern: positive for CD29, CD44, CD59,
CD71, CD73, CD90, CD105, CD106, CD146, CD166,
CD271, and HLA class I and negative for CD14, CD34,
CD45, and HLA class II (Figure 1B).
Cell growth, proliferation and viability
MSCs labeled with SPIO immediately exposed to mag-
netic fields before adhesion to the plastic surface (JPR-
MSC + m(0 h)) initially accumulated in the area directly
above the magnets at high density, adhered there guided
by the magnetic force and grew out from this area
throughout the culture flask or 6-well plates (Figure
2D+E). Unlabeled MSCs immediately exposed to mag-
netic fields before adhesion to the plastic surface showed
no accumulation at the area above the magnets. Labeled
or unlabeled MSCs exposed to magnetic fields after adhe-
sion to the plastic surface showed no accumulation at the
area above the magnets. MSCs labeled with SPIO and
exposed to magnetic fields grew according to the mag-
netic flux lines (Figure 2F) whereas unlabeled MSCs with
or without exposition to magnetic fields and labeled
MSCs without exposition to magnetic fields showed the
usual clonogenic growth clusters without general order in
the culture flasks (Figure 2G).
The proliferation rate and viability rate of unlabeled
MSCs and labeled MSCs with and without exposition to
magnetic fields showed no differences (Figure 3 + 4).
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Migration capacity
The migration capacity of unlabeled MSCs and labeled
MSCs with and without exposition to magnetic fields
showed no differences (Figure 5).
Ability of colony formation
A possible influence of the exposition to magnetic fields
on the ability of colony formation of labeled and unla-
beled MSCs was investigated by two settings:
In the first setting, the colony forming assay was started
at the beginning of the exposition to magnetic fields and
directly after labeling (= colony forming ability of MSCs
under exposition to magnetic fields). Here, the ability of
colony formation of labeled MSCs was significantly
reduced compared to unlabeled MSCs. The reduced abil-
ity of colony formation could be observed on labeled
MSCs with and without exposition to magnetic fields.
Exposition to magnetic fields did not influence the ability
of colony formation of unlabeled MSCs whereas immedi-
ate exposition of labeled MSCs to magnetic fields signifi-
cantly decreased the ability of colony formation
compared to labeled MSCs exposed to magnetic fields
after 24 h (Figure 6A).
In the second setting, the colony forming assay was
started at the end of the exposition to magnetic fields and
12 days after labeling (= colony forming ability of MSCs
after exposition to magnetic fields). Here, the ability of
colony formation of labeled MSCs immediately exposed
to magnetic fields was significantly enhanced compared
to unlabeled MSCs without exposition to magnetic fields.
No other alteration or reduction of the ability of colony
formation of labeled MSCs could be observed in this set-
ting (Figure 6B).
Gene expression
A possible influence of the exposition to magnetic fields
on gene expression of labeled and unlabeled MSCs was
investigated by microarrays analyzing the mRNA expres-
Figure 1 Characterization of human MSCs. Specific staining for adipogenesis (lipid vacuoles are stained in red), osteogenesis (alkaline phosphatase 
is stained in pink-violet) and chondrogenesis (mucopolysaccharides are stained blue-bluish green). Scale bar indicate 50 μm (A). FACS analyses of hu-
man MSCs: The MSCs are positive for CD29, CD44, CD59, CD71, CD73, CD90, CD105, CD106, CD146, CD166, CD271, and HLA class I and negative for 
CD14, CD34, CD45, and HLA class II. Black graph: specific antibody, white graph: isotype control (B).Schäfer et al. BMC Cell Biology 2010, 11:22
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sion of the whole genome. Exposition of labeled MSCs to
magnetic fields led to an up regulation of CD93 and cad-
herin 7 and to a down regulation of Zinc finger FYVE
domain. Exposition of unlabeled MSCs to magnetic fields
led to an up regulation of CD93, lipocalin 6, sialic acid
acetylesterase, and olfactory receptor and to a down reg-
ulation of ubiquilin 1 (Figure 7A, Supplemental Table 1).
However, on protein level the expression of the extracel-
lulary localized proteins CD93 and cadherin 7 was not
affected (Figure 7B).
Differentiation
To evaluate the possible influence of the exposition to
magnetic fields on the differentiation potential of labeled
and unlabeled MSCs the expression of distinct lineage
associated markers was quantitatively analyzed by qRT-
PCR. Exposition to magnetic fields led to a significantly
enhanced expression of lipoprotein lipase and peroxi-
some proliferator-activated receptor gamma under adi-
pogenic differentiation of labeled MSCs compared to
unlabeled MSCs. Moreover, under adipogenic differenti-
ation the expression of lipoprotein lipase and of peroxi-
some proliferator-activated receptor gamma was
significantly enhanced in labeled MSCs exposed to mag-
netic fields compared to labeled MSCs without exposi-
tion to magnetic fields (Figure 8A). This indicates an
enhancement of adipogenesis of labeled MSC under the
e x p o s i t i o n  t o  m a g n e t i c  f i e l d s .  E x p o s i t i o n  t o  m a g n e t i c
fields led to a reduced expression of alkaline phosphatase
under osteogenic differentiation of unlabeled MSCs com-
pared to unlabeled MSCs without exposition to magnetic
fields (Figure 8B). This indicates an impairment of osteo-
Figure 2 Magnets, magnetic fields and formation of human MSCs labeled with SPIO. 3D-visualization of the magnetic fields by cuttings of iron 
in 75 cm2 culture flasks (A) and 6-well plates (B). The magnets (C) were positioned under the culture flasks and 6-well plates. SPIO-labeled MSCs im-
mediately exposed to the magnetic fields at the time of seeding immediately accumulated in the area over the magnets as identifiable by the red-
brown particles (= SPIO) by light microscopy (D) and additional blue colour after cell staining with Coomassie blue (E). Microphotographs show the 
orientation of the SPIO-labeled MSCs according to the magnetic flux lines under exposition to magnetic fields (F), whereas unlabeled MSCs with or 
without exposition to magnetic fields and labeled MSCs without exposition to magnetic fields showed the usual clonogenic growth clusters without 
general order in the culture flasks (G). Scale bars indicate 50 μm.Schäfer et al. BMC Cell Biology 2010, 11:22
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genesis of unlabeled MSCs under the exposition to mag-
netic fields. Labeled and unlabeled MSCs showed no
significant differences in expression of collagen 2 under
exposition to magnetic fields (Figure 8C).
Electron microscopy and quantification of the TIL
Independently on exposition to magnetic fields, com-
plexes of SPIO were localized on the surface of the MSCs
without detectable uptake of SPIO into the cells directly
after labeling (Figure 9A-C). Seven days after labeling,
exposition to magnetic fields led to a significant enhance-
ment of the TIL of MSCs compared to labeled MSCs
without exposition to magnetic fields. Immediate exposi-
tion to magnetic fields was more effective than exposition
after 24 h (Figure 9D). Eleven days after labeling, the
highest TIL was again achieved after immediate exposi-
tion to magnetic fields, whereas the TIL of the labeled
MSCs exposed after 24 h to magnetic fields was not dif-
ferent from the TIL of the labeled MSCs without exposi-
tion to magnetic fields (Figure 9E).
MRI
SPIO labeled MSCs with and without exposition to mag-
netic fields could be detected by MRI in vitro in high
quality. The lowest detectable cell number was 1 × 103
labeled MSCs after immediate exposition to magnetic
fields. The detection limit by MRI of labeled MSCs
exposed after 24 h to magnetic fields was 2 × 103 MSCs
and the detection limit by MRI of labeled MSCs without
exposition to magnetic fields was 5 × 103 MSCs (Figure
10A-C). According to the TIL, the most effective labeling
protocol was using SPIO in combination with immediate
exposition to magnetic fields.
Discussion
MRI has been successfully established detecting in vivo
MSCs labeled with SPIO [4,5,12]. However, despite initial
reports that labeling of MSCs with SPIO is safe without
affecting the MSC's biology, recent studies report on
influences of SPIO-labeling on metabolism and function
of MSCs [17,19]. Moreover, in an animal model of multi-
ple sclerosis the application of SPIO-labeled MSCs led to
an aggravation of the symptoms whereas unlabeled MSCs
ameliorated the symptoms [29]. Therefore, prior to clini-
cal studies safe and efficient SPIO-based labeling proto-
cols for stem cells have to be established. With respect to
the requirements of good manufacturing practice these
protocols must include on the one hand comprehensive
Figure 3 Proliferation rate of human MSCs. The proliferation rate of unlabeled MSCs with (MSC + m(24 h)) and without (MSC - m) exposition to 
magnetic fields and labeled MSCs with (JPR-MSC + m(24 h)) and without (JPR-MSC - m) exposition to magnetic fields showed no significant differenc-
es. Error bars: SEM.
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Figure 4 Viability rate of human MSCs. The viability rate of unlabeled MSCs with (MSC + m(0 h), MSC + m(24 h)) and without (MSC - m) exposition 
to magnetic fields and labeled MSCs with (JPR-MSC + m(0 h), JPR-MSC + m(24 h)) and without (JPR-MSC - m) exposition to magnetic fields showed 
no significant differences. Error bars: SEM.
0
0.2
0.4
0.6
0.8
1
MSC  m MSC +m(0h) MSC +m(24h) JPR MSC  m JPR MSC +m(0h) JPR MSC +m (24h)
v
i
a
b
i
l
i
t
y
 
r
a
t
e
Figure 5 Migration capacity of human MSCs. The migration capacity of unlabeled MSCs with (MSC + m(0 h), MSC + m(24 h)) and without (MSC - 
m) exposition to magnetic fields and labeled MSCs with (JPR-MSC + m(0 h), JPR-MSC + m(24 h)) and without (JPR-MSC - m) exposition to magnetic 
fields showed no significant differences. Error bars: SEM.
0
20
40
60
80
100
120
140
160
MSC -m MSC +m(0h) MSC +m(24h) JPR-MSC -m JPR-MSC +m(0h) JPR-MSC +m(24h)
c
e
l
l
s
 
/
 
m
m
2Schäfer et al. BMC Cell Biology 2010, 11:22
http://www.biomedcentral.com/1471-2121/11/22
Page 7 of 17
studies on possible side effects of SPIO-labeling, and on
the other hand the optimization of the imaging properties
of the SPIO formulation. Exposition of cells and tissues to
high magnetic fields is the functional principle of MRI
and iron labeled stem cells can be directed by the mag-
netic force in vitro and in vivo [21-23].
The imaging properties of labeling protocols using iron
nanoparticles correlate to the TIL of the MSCs [19]. In
our study we investigated if and how the magnetic force
could be used to enhance the amount of magnetic SPIO
in/on MSCs in order to optimize the imaging properties.
As described previously, the highest TIL of human MSCs
without exposition to magnetic fields could be achieved
by labeling with SPIO + TA (JPR) and the detection limit
by MRI of SPIO labeled rat MSCs + T A (JPR) without
exposition to magnetic fields is 5 × 103 MSCs [19]. In our
study we confirmed this detection limit by MRI for
human MSCs and immediate exposition of labeled MSCs
to magnetic fields maximized the TIL resulting in a mini-
mal detection rate of 1 × 103 MSCs by a clinical MR scan-
ner. It has to be emphasized that the number of detected
cells depends on the sequence used and is not a value in
itself. Therefore, comparing protocols with the same
sequence as performed in this work does not necessarily
reflect an advantage to different labeling protocols using
different imaging settings.
The optimized labeling and imaging properties
remained stable over a period of eleven days after label-
ing. Therefore, optimized imaging of the cellular graft
would be feasible within the first crucial two weeks after
Figure 6 Colony forming ability of human MSCs. Colony forming ability of human MSCs under exposition to magnetic fields (A): The ability of col-
ony formation of labeled MSCs (JPR-MSC - m), (JPR-MSC + m(0 h), (JPR-MSC + m(24 h)) was significantly reduced compared to unlabeled MSCs (MSC 
- m), (MSC + m(0 h), (MSC + m(24 h)). Exposition to magnetic fields did not influence the ability of colony formation of unlabeled MSCs (MSC - m), 
(MSC + m(0 h), (MSC + m(24 h)) compared among one another. Immediate exposition of labeled MSCs to magnetic fields (JPR-MSC + m(0 h)) signif-
icantly (*) decreased the ability of colony formation compared to labeled MSCs exposed to magnetic fields after 24 h (JPR-MSC + m(24 h)). Colony 
forming ability of human MSCs after exposition to magnetic fields (B): 12 days after labeling, the ability of colony formation of labeled MSCs immedi-
ately exposed to magnetic fields (JPR-MSC + m(0 h)) was significantly (*) enhanced compared to unlabeled MSCs without exposition to magnetic 
fields (MSC - m). No other changes of the ability of colony formation of labeled MSCs could be observed in this setting. Error bars: SEM.
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transplantation. The combination of enhanced retention
of SPIO in MSCs with more intensive exposition of MSCs
to SPIO could be regarded as the major mechanisms of
the enhanced efficiency of this labeling protocol. This
optimized labeling protocol using magnetic forces in
combination with SPIO and TA did not affect cell growth,
proliferation, viability and migration capacity of MSCs.
The ability of colony formation is a basic property of
MSCs reflecting their clonogenic potential related to
their stemness [30]. In our study, the ability of colony for-
m a t io n of  la be l ed MSC s u nde r e x posi ti on t o m agnet ic
fields was significantly reduced compared to unlabeled
MSCs, and the reduced ability of colony formation could
be observed on labeled MSCs with and without exposi-
tion to magnetic fields. These observations correlate to a
prior study reporting on the reduced ability of colony for-
mation of MSCs by labeling with JPR [17]. Exposition to
magnetic fields did not influence the ability of colony for-
mation of unlabeled MSCs whereas immediate exposi-
tion of labeled MSCs to magnetic fields significantly
decreased the ability of colony formation compared to
labeled MSCs exposed to magnetic fields after 24 h. The
fact that the functional influence on the ability of colony
formation of MSCs by the magnetic force was only
observed on labeled MSCs addresses the issue of the role
of SPIO. Whether the observed effect was exclusively
caused by the magnetized SPIO or the magnetized SPIO
aggravated a possible influence of the magnetic force per
se remains unanswered but keeping in mind that SPIO
are superparamagnetic nanoparticles that are fixed to the
MSCs, it is reasonable to assume that the tight growth
pattern of SPIO labeled MSCs caused by their accumula-
tion over the area of high density magnetic fields was
responsible for the reduced ability of colony formation.
Figure 7 Influence of exposure to magnetic fields on gene expression of human MSCs. Expression of mRNA (A): Exposition of labeled MSCs to 
magnetic fields led to an up regulation of CD93 and cadherin 7 and to a down regulation of Zinc finger FYVE domain. Exposition of unlabeled MSCs 
to magnetic fields led to an up regulation of CD93, lipocalin 6, sialic acid acetylesterase, and olfactory receptor and to a down regulation of ubiquilin 
1. Expression of proteins (B): No difference of the expression of CD93 and cadherin 7 could be detected by FACS. The very weak expression of CD93 
and cadherin 7 is depicted by comparison to the isotype-control and the strongly expressed CD44.Schäfer et al. BMC Cell Biology 2010, 11:22
http://www.biomedcentral.com/1471-2121/11/22
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The colony forming ability of MSCs 12 days after exposi-
tion to magnetic fields was not reduced, the groups show-
ing a reduction of the ability of colony formation under
exposition to magnetic fields recovered completely, and
the ability of colony formation of labeled MSCs after
immediate exposition to magnetic fields was even
enhanced. These data confirm the acute influence of
labeling and magnetic fields on the ability of colony for-
mation showing that after a time period of 12 days after
labeling and 10 days after terminating the exposition to
magnetic fields no adversive long term effects on the abil-
ity of colony formation may occur.
The exposition to magnetic fields of labeled and unla-
beled MSCs influenced the expression of CD93, lipocalin
6, cadherin 7, Zinc finger FYVE domain, sialic acid acety-
lesterase, olfactory receptor and ubiquilin 1 on mRNA
level. However, analyses on protein level showed that the
expression of the extracellulary localized proteins CD93,
a glycoprotein involved in innate immunity, inflammation
and adhesion to endothelium [31-33], and cadherin 7, a
protein involved in cell adhesion and in cell dispersion
and migration along migratory pathways [34], was not
affected. Under the exposition to magnetic fields the adi-
pogenic differentiation of SPIO labeled MSCs was
enhanced, whereas no influence of the magnetic fields on
the adipogenic differentiation of unlabeled MSCs could
be detected. Recent studies showed no influence of SPIO
labeling on adipogenic differentiation of MSCs [17,29].
Therefore, the enhanced adipogenic differentiation of the
labeled MSCs is most likely caused by the tight growth
density of the labeled MSCs over the area of magnetic
fields. Under the exposition to magnetic fields the osteo-
Figure 8 Influence of exposure to magnetic fields on differentiation of human MSCs. Exposition to magnetic fields led to a significantly (*) en-
hanced expression of lipoprotein lipase and peroxisome proliferator-activated receptor gamma under adipogenic differentiation of labeled MSCs 
(JPR-MSC + m(0 h)) compared to unlabeled MSCs (MSC + m(0 h)) and compared to labeled MSCs without exposition to magnetic fields (JPR-MSC - 
m). (A). Exposition to magnetic fields led to a reduced expression of alkaline phosphatase under osteogenic differentiation of unlabeled MSCs (MSC 
+ m(0 h)) compared to unlabeled MSCs without exposition to magnetic fields (MSC - m) (B). Labeled (JPR-MSC + m(0 h)) and unlabeled MSCs (MSC 
+ m(0 h)) showed no significant differences in expression of collagen 2 under exposition to magnetic fields (C). Error bars: SEM.
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
+m(0h) -m
e
x
p
r
e
s
s
i
o
n
 
L
P
L
MSC
JPR MSC *
A. adipogenic differentiation
B. osteogenic differentiation
0
0.002
0.004
0.006
0.008
0.01
0.012
0.014
0.016
0.018
+m(0h) -m
e
x
p
r
e
s
s
i
o
n
 
P
P
A
R

MSC
JPR MSC
**
0
0.005
0.01
0.015
0.02
0.025
0.03
+m(0h) -m
e
x
p
r
e
s
s
i
o
n
 
A
L
P
MSC
JPR MSC
*
C. chondrogenic differentiation
0
0.0005
0.001
0.0015
0.002
0.0025
0.003
+m(0h)
e
x
p
r
e
s
s
i
o
n
 
C
O
L
L
2
MSC
JPR MSC
r
e
l
.
 
t
o
 
G
A
P
D
H
r
e
l
.
 
t
o
 
G
A
P
D
H
r
e
l
.
 
t
o
 
G
A
P
D
H
r
e
l
.
 
t
o
 
G
A
P
D
H
*Schäfer et al. BMC Cell Biology 2010, 11:22
http://www.biomedcentral.com/1471-2121/11/22
Page 10 of 17
genic differentiation of unlabeled MSCs was reduced
indicating an influence of the magnetic fields on the dif-
ferentiation. In a recent study the membrane potential
was identified as an important factor regulating the adi-
pogenic and osteogenic differentiation of MSCs showing
that depolarization of MSCs prevents differentiation and
hyperpolarization upregulated osteogenic markers [35].
The paramagnetic ions Na+ and K+ are crucial factors in
the maintenance of the membrane potential, and their
distribution may be influenced by magnetic fields. Kan-
garlu et al. performed systematic analyzes of the effect of
an 8.0 T static magnetic field on physiological and/or
cognitive function reporting on important changes in the
electrocardiogram (ECG) which were related both to the
position of the subject in the magnet and to the absolute
strength of the magnetic field [36]. Although no cognitive
changes and no evidence of detectable changes in body
temperature, heart rate, respiratory rate, systolic pres-
Figure 9 Electron microscopy and quantification of TIL of human MSCs. Independently on exposition to magnetic fields, complexes of SPIO 
(black arrows) were localized on the surface of the MSCs without detectable uptake of SPIO into the cells directly after labeling (A = JPR-MSC + m (0 
h), B = JPR-MSC + m (24 h), C = JPR-MSC - m). Seven days after labeling, exposition to magnetic fields led to a significant (*) enhancement of the TIL 
of MSCs (JPR-MSC + m(0 h), JPR-MSC + m(24 h)) compared to labeled MSCs without exposition to magnetic fields (JPR-MSC - m). Immediate exposition 
to magnetic fields (JPR-MSC + m(0 h)) was more effective than exposition after 24 h (JPR-MSC + m(24 h)) (D). Eleven days after labeling, the highest 
TIL was again achieved after immediate exposition to magnetic fields (JPR-MSC + m(0 h)), whereas the TIL of the labeled MSCs exposed after 24 h to 
magnetic fields (JPR-MSC + m(24 h)) was not different from the TIL of the labeled MSCs without exposition to magnetic fields (JPR-MSC - m) (E). Error 
bars: SEM.
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sure, and diastolic blood pressure myocardial stiffness
index, cardiac output, systolic volume, troponin, and
potassium levels were detected [36], the impact on the
polarization of a cell mass, as reflected by the changes in
the ECG, demonstrates that the static magnetic field has
an influence on cell physiology in vivo. In our study an
innovative labeling protocol with optimized imaging
properties for tracking MSCs by MRI using SPIO in com-
bination with magnetic fields was established. The static
magnetic field was for the first time identified as an inde-
pendent factor which can functionally affect the biology
and function of human MSCs. Further in vivo investiga-
tions are needed to elucidate the molecular mechanisms
of the interaction of magnetic fields with stem cell biol-
ogy.
Conclusions
In our study an innovative labeling protocol for tracking
MSCs by MRI using SPIO in combination with magnetic
fields was established. Both, SPIO and the static magnetic
field were identified as independent factors which affect
the functional biology of human MSCs. Further in vivo
investigations are needed to elucidate the molecular
mechanisms of the interaction of magnetic fields with
stem cell biology.
Methods
Bone marrow preparation
Our study was approved by the local institutional review
board (ethical committee). Bone marrow (BM) was taken
under sterile conditions from randomly chosen donors
(neither metabolic nor neoplastic diseases) with
informed consent during orthopaedic operations: From
each donor 5 ml of whole BM was collected in a sterile
heparinized syringe.
MSC isolation and cell culture
To isolate MSCs from whole BM we used the density gra-
dient technique as described previously [37]. Briefly, 5 ml
bone marrow was resuspended in 10 ml PBS (Cambrex
Bio Science, Verviers, Belgium) and laid over 15 ml Lym-
phoflot (sodium diatrizoate 9.1% [w/v], ficoll 5.7% [w/v];
Biotest AG, Dreieich, Germany). After centrifugation (20
minutes at 1000 × g without braking) the mononuclear
cells were harvested, washed twice with PBS, transferred
to a 75 cm2 culture flask (Corning Inc., Schiphol-Rijk,
Netherlands) and incubated (37°C, 5% humidified CO2)
with normal medium containing desoxyribonucleotides,
ribonucleotides, ultra glutamine 1 (α-MEM, Cambrex Bio
Science), 100 I.U./ml Penicillin (Cambrex Bio Science),
100 μg/ml Streptomycin (Cambrex Bio Science) and 10%
Figure 10 Magnetic resonance imaging of SPIO-labeled human MSCs. The lowest detectable cell number was 1 × 103 labeled MSCs after imme-
diate exposition to magnetic fields (JPR-MSC + m(0 h)) (C). The detection limit by MRI of labeled MSCs exposed after 24 h to magnetic fields (JPR-MSC 
+ m(24 h)) was 2 × 103 MSCs (B) and the detection limit by MRI of labeled MSCs without exposition to magnetic fields (JPR-MSC - m) was 5 × 103 MSCs 
(A).Schäfer et al. BMC Cell Biology 2010, 11:22
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heat inactivated Fetal Calf Serum (FCS) (Cambrex Bio
Science). After 24 hours the non-adherent cells were
removed and the adherent cells were cultured and char-
acterized.
Characterization of human MSCs by in vitro differentiation 
and FACS analysis
MSCs are functionally characterized by in vitro differen-
tiation assays [38]. We evaluated the differentiation
potential into three mesenchymal lineages: Adipogenic,
osteogenic and chondrogenic differentiation. The MSCs
were treated for 21 days with adipogenic medium, osteo-
genic medium or normal medium (control) as described
previously [39,40] (modification: No addition of Amphot-
ericin B): Adipogenic medium contained DMEM + 20%
FCS with 1.0 μM dexamethasone (Sigma, Deisenhofen,
Germany), 0.5 mM isobutylmethylxanthine (Sigma), 0.2
mM indomethacine (Sigma) and 0.01 mg/ml insulin
(Sigma). Osteogenic medium contained normal medium
with 10-8 M dexamethasone (Sigma), 0.2 mM ascorbic
acid (Sigma) and 10 mM β-glycerolphosphate (Sigma).
After 21 days the cell culture was stained with oil red O
for in vitro adipogenesis. Briefly, after removal of the
medium and washing twice with PBS, 2 ml of 10% forma-
lin were added followed by an incubation time of 30 min-
utes. After removing the formalin and washing the cell
layer with sterile water 2 ml of isopropanol (60%, Bio
Whittaker, Verviers, Belgium) were added for 2 minutes.
The isopropanol was removed and 2 ml of a filtered
working solution of oil red O (3 parts oil red O stock
solution [300 mg oil red O powder (Sigma) + 100 ml 99%
isopropanol (Sigma)] + 2 parts deionized water) were
pipetted onto cells and left there for five minutes. There-
after the plate was rinsed with tap water and the cells
were counterstained with 2 ml haematoxylin (Sigma) for
1 minute. The osteogenic differentiated cells as well as
control cells were cytochemically stained for alkaline
phosphatase using a commercial staining kit according to
the manufacturer's (Cambrex Bio Science) recommenda-
tions: after removal of the medium and washing twice
with PBS, 2 ml citrate fixative (12.5 ml citrate solution +
32.5 ml acetone + 4 ml 37% formaldehyde) were added for
1 minute, followed by staining with 2 ml alkaline-dye (0.5
ml sodium nitrite + 0.5 ml FRV-alkaline solution + 22.5
ml deionized water + 0.5 ml naphtole AS-BI alkaline solu-
tion) for 30 minutes. The cell layer was washed twice and
counterstained with 2 ml haematoxylin (Sigma) for 1
minute. Chondrogenic differentiation was performed
using a commercially available mesenchymal functional
differentiation kit (Cat. Nr. SC006, R&D Systems, Wies-
baden, Germany). The MSC of each population were
treated with the chondrogenic differentiation procedure:
250 × 103 cells were transferred into a 15 ml tube. After
centrifugation (200 × g), 1.0 ml basal medium (D-MEM/
F-12, Bio Whittaker) and 0.5 ml chondrogenic differenti-
ation medium were added and replaced every 2-3 days.
The cell suspension was cultured in the tube forming a
solid pellet. After 14 days the chondrocyte pellet was
removed, squeezed on a glass slide and stained with 1%
Alcian Blue 8GX (Serva, Heidelberg, Germany) in 3%
acetic acid (pH 2.5).
FACS analysis was performed with FACScan (BD Bio-
sciences, San Jose, CA, USA) using BD CellQuest Pro
software. At subconfluency (1 × 106 cells) the cells were
detached with Accutase™ (PAA Laboratories, Cölbe, Ger-
many)) and washed (PBS + AccuMax™ [PAA Laborato-
ries]). Each probe contained a cell suspension with 5 ×
105 cells in FACS-buffer (PBS + 1% bovine serum albu-
mine [Sigma] + 0.1% FCS [Cambrex Bio Science]). The
PE-conjugated antibody (anti-human-CD14, -CD29, -
CD34, -CD44, -CD45, -CD59, -CD71, -CD73, -CD90, -
CD105, -CD106, -CD146, -CD166, -CD271, HLA class I,
HLA class II) was added. After an incubation time of 20
minutes and 2 washing steps the probe was ready for
analysis. All antibodies, except for anti-human-CD271
(Miltenyi Biotech, Bergisch Gladbach, Germany), were
from BD Biosciences.
Contrast Media and cell labeling
Resovist® (SHU 555A, Bayer Schering AG, Berlin, Ger-
many), an MRI contrast agent already approved for clini-
cal use in Europe, Japan and Australia, is organ-specific
and used for liver imaging [41-43]. It consists of super-
paramagnetic iron oxide (SPIO) nanoparticles (4-6 nm)
[44] coated with carboxydextran (mean hydrodynamic
diameter 60 nm), which is accumulated by phagocytosis
in von Kupffer cells. For an enhanced iron loading of the
cells, the transfection reagent (TA) jetPEI™, a linear poly-
ethylenimine (PolyPlus Transfection, Illkirch, France) was
used. Cell labeling was performed for 4 h with 60 μg/ml
Resovist® in combination with jetPEI™ in 6-well-plates
seven days after seeding of 5 × 104 cells as described pre-
viously [19]. First, 10 μl of the TA in a total volume of 50
μl PBS was carefully added to 50 μl of the Resovist® solu-
tion, mixed and preincubated for 30 min. The following
incubation was carried out in the incubator at standard
conditions (37°C, 5% humidified CO2). After the labeling,
cells were washed three times with PBS, harvested and
processed for further plating with or without magnets.
Magnets
Magnets (magnetic material: NeoSint N33H (alloy of
neodymium, dysprosium, boron, cobalt and iron), rema-
nence: > 1.140 mT, magnetic field force on the surface:
600 mT, coercive force, BHC = > 851 kA/m, JHC = >
1.353 kA/m, max. residual energy > 247 kJ/m3, magneti-Schäfer et al. BMC Cell Biology 2010, 11:22
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sation direction: axial, coating: nickel, diameter: 15 mm,
thickness: 3 mm (ppm materials GmbH, 70794 Filder-
stadt, Germany)) were fixed on plastic dishes and the 75
cm2 culture flasks and 6-well plates were firmly posi-
tioned with direct contact above the magnets (Figure 2A-
C). The 75 cm2 culture flasks were used for the prolifera-
tion and viability assays, the transmission electron
microscopy, the quantification of the total iron load and
the adipogenic and osteogenic differentiation analyses,
the 6-well plates were used for the colony formation anal-
yses and the microarray experiments. The following con-
ditions were investigated: unlabeled MSCs without
exposition to magnetic fields (MSC - m), unlabeled MSCs
with exposition to magnetic fields 24 hours after seeding
into the 75 cm2 culture flasks and 6-well plates (MSC +
m(24 h)), unlabeled MSCs with exposition to magnetic
fields immediately after seeding into the 75 cm2 culture
flasks and 6-well plates and before adhesion to the plastic
surface (MSC + m(0 h)), SPIO-labeled MSCs without
e x p o s i t i o n  t o  m a g n e t i c  f i e l d s  ( J P R - M S C  -  m ) ,  S P I O -
labeled MSCs with exposition to magnetic fields 24 hours
after seeding into the 75 cm2 culture flasks and 6-well
plates (JPR-MSC + m(24 h)), and SPIO-labeled MSCs
with exposition to magnetic fields immediately after
seeding into the 75 cm2 culture flasks and 6-well plates
and before adhesion to the plastic surface (JPR-MSC +
m(0 h)). The exposition to the magnetic fields continued
until the end of the respective experiments.
Proliferation assays and determination of viability
Proliferation assays were performed in 75 cm2 culture
flasks positioned with direct contact above the magnets.
Labeled and control cells were seeded at 3 × 105 cells/
flask in standard medium (α-MEM, 100 I.U./ml Penicil-
lin, 100 μg/ml Streptomycin and 10% Fetal Calf Serum).
The incubation was carried out in the incubator at stan-
dard conditions (37°C, 5% humidified CO2). The labeled
and unlabeled MSCs were exposed to magnetic field
immediately after seeding, 24 hours after seeding into the
75 cm2 culture flasks or there was no exposure (control
group).
Medium was changed every 3 days. At subconfluence
(90%) the cells were detached with Accutase (PAA Labo-
ratories, Cölbe, Germany) and counted with a CASY®2
Analyser (CASY®2-Cell Counter and Analyser System,
Model TT, Roche Diagnostics, Mannheim, Germany).
The experiments were performed in triplicates.
Cellular viability after the different incubation condi-
tions was examined with the help of a CASY®2 Analyser
according to the ECE method described by Lindl et al
[45] and the viability-SOP of the manufacturer.
Quantification of the total iron load (TIL)
After reaching subconfluence MSC + m(24 h), MSC +
m(0 h) and (MSC - m), all Resovist®/jetPEI™ labeled, were
washed three times with PBS, harvested with Accutase
and counted with a CASY®2 Analyser. A cell pellet con-
taining 1 × 105 cells was dried for 2 hours at 80°C. Then
samples were incubated overnight at room temperature
and another 2 hours at 60°C in perchloric and nitric acid
at a 3:1 ratio to completely digest the cells and expose
iron oxide from the dextran coated nanoparticles. For
photometric determination of the TIL, a Ferrozine-based
spectrophotometric assay (Eisen Ferene S Plus®, Rolf
Greiner Biochemica, Flacht, Germany) was used. Fe2+
forms a blue complex with Ferene which can be measured
at 595 nm. The extinction of the sample relates directly to
the iron concentration, calculated with the help of a
defined standard. All experiments were performed in
triplicates.
Transmission electron microscopy
To assess the uptake and localization of the SPIO nano-
particles and their possible influence on the cellular ultra-
structure, electron microscopy was performed. Cells
grown as described above in the proliferation section and
treated as indicated were fixed in 2.5% glutaraldehyde
(Paesel-Lorei, Frankfurt, Germany) buffered with 0.1 M
cacodylate buffer (pH 7.4), postfixed in 1% OsO4 in 0.1 M
cacodylate buffer and scraped off the plastic. The pellet
was then dehydrated in an ethanol series (50%, 70%, 96%,
100%). The 70% ethanol was saturated with uranyl acetate
for contrast enhancement. Dehydration was completed in
propylene oxide. The specimens were embedded in
Araldite (Serva). Ultrathin sections were produced on a
FCR Reichert Ultracut ultramicrotome (Leica, Bensheim,
Germany), mounted on pioloform-coated copper grids,
contrasted with lead citrate and analyzed and docu-
m e n t e d  w i t h  a n  E M  1 0 A  e l e c t r o n  m i c r o s c o p e  ( Z e i s s ,
Oberkochen, Germany).
In vitro MRI
A n  a g a r  m a t r i x  w a s  u s e d  a s  s u i t a b l e  e n v i r o n m e n t  f o r
imaging SPIO labeled MSCs. The agar solution (1%) was
boiled and embedded in nonferromagnetic boxes before
becoming stable. By using a special stamp a series of iden-
tical cone shaped cavities was created in the agar block.
For MR measurement cell numbers from one thousand to
two hundred thousand Resovist® labeled MSCs were used
(JPR-m; JPR + m(24 h); JPR + m(0 h)). Cells were centri-
fuged at 200 × g for 5 minutes, dissolved in 8% gelatine
(20 μl) and implanted into the cone shaped cavities within
the agar matrix. After solidification of the gelatine the
hollows were closed with agar. Thus, it was possible to
achieve a homogenous distribution of the target cells in aSchäfer et al. BMC Cell Biology 2010, 11:22
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defined volume of 20 μl within a homogenous agar block.
Cells were scanned in a clinically used MR scanner at 3.0
T (Magnetom Trio, Siemens Healthcare, Erlangen, Ger-
many) using the wrist coil of the manufacturer. Imaging
was performed with a conventional 3D gradient echo
sequence with a Field-of-View (FoV) of 83 × 120 and a
matrix size of 176 × 256, resulting in a resolution of 0.21
m m .  T h e  e c h o  t i m e  ( T E )  w a s  c h o s e n  a s  t h e  v a r i a b l e
parameter and was varied between 5 ms and 15 ms in
steps of 5 ms with a repetition time (TR) of 70 ms and a
flip angle of 14° according to the T1-value of the agarose
gel of 2000 ms. Further parameters were: readout band-
width (BW) 220 Hz/Px, 32 slices with a slice thickness of
0.5 mm. The acquisition time was then for one average
about 6.5 minutes. Signal extinction was described by
measuring the dimensions of the signal artifacts in all
directions.
Migration assays
The migratory ability of labeled and control MSCs was
investigated with cells which finished the proliferation
assay. Every six conditions were analyzed (JPR-MSC - m;
JPR-MSC + m(24 h); JPR-MSC + m(0 h) and MSC - m;
MSC + m(24 h); MSC + m(0 h). There was no magnetic
exposure during migration assay.
The MSCs were tested in 24-well compound chambers
(Falcon, Becton Dickinson, Franklin Lakes, NJ, USA) with
8 μm pore membrane inserts. Cells were washed three
times with PBS, harvested and finally seeded at a density
of 20.000 cells in the membrane inserts with 0.5 ml cell
culture medium containing 20% FCS. 0.8 ml medium
containing 20% FCS and 25 ng/ml PDGF-BB (R&D Sys-
tems), serving as a chemoattractant, was added to the
lower compartment of the plate. After incubating the
plates for 24 h at 37°C in a humidified 5% CO2 atmo-
sphere, the membrane inserts were fixed (ethanol 70%,
formaldehyde 3.5%, 10 min. respective) and stained with
Coomassie blue after mechanically removing the cells
attached to the upper surface. The cells on the lower side
of the inserts were counted with the help of a 100× mag-
nification light microscope (Zeiss, Göttingen, Germany)
using a Fuchs-Rosenthal counting-chamber. For each
condition 5 membranes have been investigated.
Colony forming assays
The clonogenic activity of the cells was determined with
the help of colony forming assays. There were two differ-
ent setups, under exposition to magnetic field and after
exposition to magnetic field. Every six conditions were
analyzed (JPR-MSC - m; JPR-MSC + m(24 h); JPR-MSC +
m(0 h) and MSC - m; MSC + m(24 h); MSC + m(0 h).
The cells were seeded at 250 cells/well in 2 ml medium
in 6-well plates (Falcon), resulting in 12 wells per condi-
tion. The plates were incubated at 37°C in a 5% CO2
atmosphere without changing medium. After 10 days, the
assays were stopped and the cells were fixed with 3.5%
formaldehyde and 70% ethanol and subsequently stained
with Coomassie blue. The total number of colonies
exceeding 50 cells per colony was counted by light
microscopy (Zeiss). Because of the intense inter-donator
variation of the clonogenic activity of the MSCs, data are
given as percentage with respect to the controls.
Investigations on gene and protein expression
Gene expression analyses were performed with Agilent
Whole Human Genome Microarrays, 4 × 44 K, Two
Color (Miltenyi Biotec).
The MSCs were seeded at 1 × 105 cells/well in 6-well
plates (Falcon). The plates were incubated at 37°C in a 5%
CO2 atmosphere, as far as they reached subconfluency
(90%), and labeled with standard protocol above, follow-
ing exposure to magnetic field for 24 h (JPR-MSC - m;
JPR-MSC + m(0 h) and MSC - m; MSC + m(0 h)). Cells
were washed three times with PBS, harvested with
Accutase, frosted in liquid nitrogen and stored at -80°C
until RNA isolation
The microarrays were performed following the manu-
facturer's protocol. RNA was isolated using standard
RNA extraction protocols (NucleoSpin® RNA II, Mach-
erey-Nagel, Düren, Germany). The RNA samples were
quality-checked via the Agilent 2100 Bioanalyzer plat-
form (Agilent Technologies, Waldbronn, Germany). The
quality of the isolated RNA was checked in a gel image
and an electropherogram using the Agilent 2100 Bioana-
lyzer expert software. In addition to the visual control,
the software allows the generation of a RNA Integrity
Number (RIN) to check integrity and overall quality of
total RNA samples. All samples showed sufficient quality
for gene expression profiling experiments.
For the linear T7-based amplification step, 1 μg of each
total RNA sample was used. To produce Cy3- and Cy5-
labeled cRNA, the RNA samples were amplified and
labeled using the Agilent Low RNA Input Linear Amp Kit
(Agilent Technologies) following the manufacturer's pro-
tocol. Yields of cRNA and the dye-incorporation rate
were measured with the ND-1000 Spectrophotometer
(NanoDrop Technologies, Wilmington, USA).
The hybridization procedure was performed according
to the Agilent 60-mer oligo microarray processing proto-
col using the Agilent Gene Expression Hybridization Kit
(Agilent Technologies). Briefly, 825 ng of the correspond-
ing Cy3- and Cy5-labeled fragmented cRNA were com-Schäfer et al. BMC Cell Biology 2010, 11:22
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bined and hybridized overnight (17 hours, 65°C) to
Agilent Whole Human Genome Oligo Microarrays 4 × 44
K using Agilent's recommended hybridization chamber
and oven. Finally, the microarrays were washed once with
6× SSPE buffer containing 0.005% N-lauroylsarcosine for
1 min at room temperature followed by a second wash
with pre-heated 0.06× SSPE buffer (37°C) containing
0.005% N-lauroylsarcosine for 1 min. The last washing
step was performed with acetonitrile for 30 sec.
Fluorescence signals of the hybridized Agilent Oligo
Microarrays were detected using Agilent's DNA microar-
ray scanner (Agilent Technologies).
The Agilent Feature Extraction Software (FES) was
used to read out and process the microarray image files.
The software determines feature intensities and ratios
(including background subtraction and normalization),
rejects outliers and calculates statistical confidences (p-
values). For determination of differential gene expression
FES derived output data files were further analyzed using
the Rosetta Resolverâ gene expression data analysis sys-
tem (Rosetta Biosoftware, Seattle, USA). This software
offers the possibility to visualize the results of the data
analysis in a double-log scatter plot.
FACS analysis of CD93 and Cadherin7 (CDH7) epitope
pattern was performed for the conditions JPR-MSC - m;
JPR-MSC + m(0 h) and MSC - m; MSC + m(0 h). 10 × 105
cells were incubated for 30 min with unconjugated anti-
CD93 antibody (R × D Systems) or anti-CDH7 antibody
(Sigma), followed by a respective Alexa488 secondary
antibody staining. A FACScan (BD Biosciences) and BD
CellQuest Pro software were used.
To evaluate the differences in differentiation potential
of the MSCs, adipogenic, osteogenic and chondrogenic
differentiation of unlabeled and labeled MSCs with and
without exposition to magnetic fields was performed.
Differentiation assays under magnetic exposition were
carried out in 75 cm2 culture flasks for adipogenic and
osteogenic differentiation, and in 15 ml Falcon tubes for
chondrogenic differentiation, all directly above the mag-
nets.
Labeled and control cells were seeded at 3 × 105 cells in
standard medium for two days. The incubation was car-
ried out in the incubator under standard conditions. The
labeled and unlabeled MSCs were exposed to magnetic
field immediately after seeding, or there was no exposure
(control group). After two days the medium was replaced
with differentiation media, as described above. Medium
was changed every 3 days. After 21 days the cells were
detached with Accutase, counted with a CASY®2 Analy-
ser, and stored in RLT-buffer (Qiagen, Hilden, Germany)
at -80°C.
To quantify the tri-lineage differentiation potential of
the MSCs, quantitative Reverse Transcription-Poly-
merase Chain Reaction Analysis (RT-PCR) was per-
formed as described previously [17]: Briefly, total
ribonucleic acid (RNA) was extracted from adipogenic,
osteogenic and chondrogenic differentiated MSCs using
RNeasy mini spin columns (Qiagen). Reverse transcrip-
tion was performed by Transcriptor First Strand cDNA
Synthesis Kit (Roche Diagnostics), using anchored-
oligo(dT)18  primer. The expression of lineage-specific
genes was determined by ready-to-use amplification
primer mixes for RT-PCR (search-LC, Heidelberg, Ger-
many) and the LightCycler™ Instrument (Roche Diagnos-
tics). In addition, the expression of Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was determined in
the same way in all samples. For relative quantification of
the gene expression, the expression of each target gene
was normalized to the expression of GAPDH in the same
sample.
Statistics/Data analysis
Following assessment of normal distribution, statistical
significance was tested by Student's t test. The data are
presented in mean ± standard error of mean (SEM), p <
0.05 was considered significant (*).
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